Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
β Scribed by Ronco, G.; Segnan, N.; Giorgi-Rossi, P.; Zappa, M.; Casadei, G. P.; Carozzi, F.; Palma, P. D.; Del Mistro, A.; Folicaldi, S.; Gillio-Tos, A.; Nardo, G.; Naldoni, C.; Schincaglia, P.; Zorzi, M.; Confortini, M.; Cuzick, J.
- Book ID
- 121806837
- Publisher
- Oxford University Press
- Year
- 2006
- Tongue
- English
- Weight
- 290 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0027-8874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Since infection with oncogenic human papillomavirus (HPV) has been considered a necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as adjuncts or replacements to Pap cytology. We designed the Canadian Cervical Cancer Screening Trial (CCCaST) to compare
## Abstract ## BACKGROUND: In the New Technologies for Cervical Cancer Screening (NTCC) randomized controlled trial, no significant increase in the sensitivity of liquidβbased cytology (LBC) was observed compared with conventional cytology. Both were interpreted by cytologists who had limited prev